Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada.

LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS"​) and Oral Thin Films ("OTF"​) for the pharmaceutical industry. While we continuously refine our TTS and OTF technologies further, we also research complementary Micro Array Patches for the transdermal delivery of large molecule, biological actives. Incorporated in 1984, we operate today from two sites in Andernach, Germany and West Caldwell/NJ, USA, plus representative office in Shanghai/China.

APR Applied Pharma Research SA develops and licenses healthcare products and technologies. It specializes in the development of oral and topical formulations in various healthcare regulatory areas ranging from Rx and OTC pharmaceuticals, nutraceuticals, dermocosmetics, and medical devices. The company was founded in 1990 and is headquartered in Balerna, Switzerland.

CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. It operates through the following divisions: Animal Health and Human Medicine. The Animal Health division produces antibiotic, enzyme, probiotic products and bird flu-related diagnostic kits and disinfectants. The Human Medicine division manufactures and supplies pharmaceuticals, pharmaceutical raw materials and functional health products. The company was founded on December 28, 1995 and is headquartered in Hwaseong-si, South Korea.

Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Aquestive is committed to addressing immediate CNS challenges by furthering its strong pipeline of products. As the undisputed leader in developing and delivering drugs via its proprietary technologies, the Company also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms.

Firson Co. Ltd. is a private company headquartered in the South Korea. The firm provides hospital services.

Zim Laboratories is a manufacturer of pharmaceutical products. They provide medicines, oral thin films, pre-formulation intermediates, and products for regulated markets. They have internal R&D resources to provide a variety of non-infringing drug delivery systems built on process innovations that increase patient compliance and lower treatment costs.

SEWON E&C Co., Ltd. engages in the manufacture and sale of chemical plant equipment and machinery. It operates through the following businesses: Process Equipment, Power Limb and Regenerative Medical System. The Process Equipment business provides drums, reactors, heat exchangers, columns, and air cooled heat exchangers. The Power Limb business manufactures pump, valve, unit, cylinder, and others. The Regenerative Medical System division offers cell therapy, bio collage, and Regenerative Medical platform. The company was founded in 1971 and is headquartered in Changwon-si, South Korea.

VeroScience LLC develops and markets biotechnology and healthcare products. The firm also develops novel, practical, and effective therapies for chronic debilitating human diseases such as Type 2 diabetes, metabolic syndrome, autoimmune disease, and cancer through interdisciplinary basic research. The company was founded by Anthony H. Cincotta in 2001 and is headquartered in Tiverton, RI.

Shilpa Medicare Ltd. engages in the manufacturing of pharmaceutical products and wind power generation. The company was founded on November 20, 1987 and is headquartered in Raichur, India.

SEOUL PHARMA Co., Ltd. engages in the manufacturing and distribution of pharmaceuticals. Its products include drugs for cardiovascular system, respiratory and digestive system, antipyretic, analgesic, anti-inflammatory, antibacterial, anti-fungal, anti-viral, cream and ointment, anti-diabetic, anti-obesity, tonics, vitamins, and minerals. The company was founded on December 23, 1985 and is headquartered in Cheongju-si, South Korea.

Labtec , a medium-size, German company, was founded in 1990 by Dr. Cordes. It considers some of the most innovative pharmaceutical companies as their R&D partners. Labtec has developed one of the first matrix type estradiol patches, which is launched worldwide (Dermestril®). Labtec GmbH provides innovative Product Development and Manufacturing Services all over the world. As a 100% subsidiary of tesa SE, Hamburg, Labtec formed itself to a leader in the field of development and making of transdermal patches and oral films.

tesa Labtec GmbH, part of maxingvest AG, is a company headquartered in Langenfeld, Germany, that manufactures pharmaceutical products. It was founded in 1990 by Günter Cordes. Detlev Radloff is currently the CEO of the firm.\nThe company says this about itself: tesa Labtec provides for over 25 years end to end services for high quality patches and oral films made in Germany. Europe, Canada, Australia and Israel have been in focus in the past – the first US launch is expected to incur in 2019. Sales & Business Development Manager Dr. Ahmad Ghoniem is looking forward to represent the drug delivery CMDO in the United States. He is supported by an experienced team of colleagues from Project Management, Sales and Marketing, always BY YOUR SIDE.

Shenzhen Taili Biomedical Co., Ltd., established on 2018-05-02, Business scope includes general business items:Research and development of new biomedical technologies,transfer,Serve.,The licensing program is:chemical preparation,Biopharmaceuticals,Chinese patent medicine preparation,Healthy food,Research and development of sanitary materials and medical supplies,Production,Sales.Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

PharMedica Ltd., has developed an “Eluting Bandage Platform”, a multifunctional, multilayer, intra-oral drug delivery method. The bandage mucoadhesive film is applied on the internal mouth tissue. Firmly attached yet totally non-irritant, it disintegrates and dissolves as the treatment progresses. The Eluting Bandage Platform is aimed at two major markets: Oral-Care, and Trans-Membrane Drug Delivery. The PharMedica Eluting Bandage is made of multiple dosage form layers. The trans-membrane functionality enables needle-free trans-mucosal drug delivery, administering the medicine directly into the blood system while bypassing the digestive and hepatic systems. The Bandage functionality enables patient treatment of ailments in the intra-oral environment.

Zhejiang Anji Shanzheng Pharmaceutical Packaging Technology Co., Ltd., established on 2008-01-03, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of rubber products;Rubber Products Sales;Manufacturing of plastic products;Sales of plastic products;Sales of hygiene products and single-use medical products;Chemical product sales(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of hygiene products and single-use medical products;Specific printed matter printing;Packaging and decoration printing(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Shanghai Jiarui Biopharmaceutical Co., Ltd., established on 2019-03-28, Business scope includes biotechnology,Technology development in the field of medical science and technology,technical consulting,Technical Services,own technology transfer(human stem cells,Except for the development and application of basic diagnosis and diagnosis and treatment technology),Health Management Consulting(except for medical diagnosis),Wholesale of cosmetics,import and export,and provide related services.(Commodities that do not involve state trade management,Quota involved,of license-managed goods,Apply according to the relevant regulations of the country;involving administrative licensing,The operating permit). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Ankur Drugs and Pharma requires that quality medicines be supplied at reasonable pricing in order to establish drug manufacturing capabilities in the Indian market.  And that was it that had this dream. Don't be surprised if this happens. Mr. Purnandu Jain, a young chartered accountant, dared to dream and ploughed the seed of his dream company under the new name of ANKUR because he felt in his heart that it would blossom into a bouquet through desire for success, true hard work, precise planning, and resource coordination. Ankur continues to be a market leader in domestic contract manufacturing for the pharmaceutical industry, and it has made good strides in its field.

HEXAL is the German generic manufacturer and belongs to the worldwide Sandoz Group with its headquarters in Holzkirchen, Bavaria. HEXAL brings biosimilars to the German market. Biosimilars are high-differentiated products, based on very complex biological molecules. Biologics, or biopharmaceuticals, are medicines produced from living organisms using biotechnology techniques. Many biologics are recombinant proteins and are manufactured using „recombinant DNA“ technology, a process that involves inserting a specific gene into a host cell to produce a particular protein. These complex state-of-the-art molecules represent a distinct regulatory class of medicine compared to traditional, chemically synthesized medicines. In Germany HEXAL employs more then 4.000 people at six sites. The company was founded in 1986 and merged with Sandoz in 2006.

InnoZen®, Inc. discovers, develops, and markets, or out licenses, innovative over-the-counter (OTC) health products that fulfill unmet consumer need. InnoZen’s goal is to develop high-quality OTC products that successfully treat common consumer health problems while minimizing the risk of side effects. InnoZen maintains a drug research and development facility and a manufacturing plant in Woodland Hills, California. Furthermore, InnoZen is considered by many to be the preeminent formulator and developer of thin film-strips that deliver drug actives and was the first company to deliver a drug active in a thin film-strip when it completed the development of the Chloraseptic® Sore Throat Relief Strips® in June 2003. InnoZen moved forward with its proprietary technology to develop two new thin film-strip products for cough. InnoZen launched its two new film-strip products under its own Suppress® brand in September 2004.